Global Clinical Trial Central Lab Services Market Size & Trends Report Segmented by Service Type (Safety Testing, Immunology, Genomic & Molecular Testing), Indication (Oncology, Cardiology, Neurology, Infectious Diseases), Phase, Modality, End-user & Regional Forecast to 2031

This report by Medi-Tech Insights provides the size of the global clinical trial central lab services market at the regional- and country-level from 2024 to 2031. The report further segments the market based on service type, phase, modality, indication, and end-user.

Market Size & Forecast (2024-2031), By Service Type, USD Million

• Safety Testing
• Immunology
• Biomarker Testing
• Genomic and Molecular Testing
• Pathological Testing
• Others

Market Size & Forecast (2024-2031), By Phase, USD Million

• Phase I
• Phase II
• Phase III

Market Size & Forecast (2024-2031), By Modality, USD Million

• Small Molecules
• Biologics
• Cell & Gene Therapy
• Others

Market Size & Forecast (2024-2031), By Indication, USD Million

• Oncology
• Cardiology
• Neurology
• Infectious Diseases
• Immunology & Autoimmune Diseases
• Others

Market Size & Forecast (2024-2031), By End-user, USD Million

• Pharmaceutical & Biotechnology Companies
• Contract Research Organizations (CROs)
• Others

Market Size & Forecast (2024-2031), By Region, USD Million

• North America
  • US
  • Canada
• Europe
  • UK
  • Germany
  • France
  • Italy
  • Spain
  • Rest of Europe
• Asia Pacific
  • China
  • India
  • Japan
  • Rest of Asia Pacific
• Latin America
• Middle East & Africa